Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 5/2021

01-05-2021 | Glioblastoma | Review Article

Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?

Authors: Precilla S Daisy, T. S. Anitha

Published in: Medical Oncology | Issue 5/2021

Login to get access

Abstract

Gliomas are one of the most devastating primary brain tumors which impose significant management challenges to the clinicians. The aggressive behaviour of gliomas is mainly attributed to their rapid proliferation, unravelled genomics and the blood–brain barrier which protects the tumor cells from chemotherapeutic regimens. Suspects of brain tumors are usually assessed by magnetic resonance imaging and computed tomography. These images allow surgeons to decide on the tumor grading, intra-operative pathology, feasibility of surgery, and treatment planning. All these data are compiled manually by physicians, wherein it takes time for the validation of results and concluding the treatment modality. In this context, the arrival of artificial intelligence in this era of personalized medicine, has proven promising performance in the diagnosis and management of gliomas. Starting from grading prediction till outcome evaluation, artificial intelligence-based forefronts have revolutionized oncological research. Interestingly, this approach has also been able to precisely differentiate tumor lesion from healthy tissues. However, till date, their utility in neuro-oncological field remains limited due to the issues pertaining to their reliability and transparency. Hence, to shed novel insights on the “clinical utility of this novel approach on glioma management” and to reveal “the black-boxes that have to be solved for fruitful application of artificial intelligence in neuro-oncology research”, we provide in this review, a succinct description of the potential gear of artificial intelligence-based avenues in glioma treatment and the barriers that impede their rapid implementation in neuro-oncology.
Literature
1.
Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18:3–9.PubMedPubMedCentral
2.
Vigneswaran K, Neill S, Hadjipanayis CG. Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification. Ann Transl Med. 2015;3:95.PubMedPubMedCentral
3.
Harder BG, Blomquist MR, Wang J, Kim AJ, Woodworth GF, Winkles JA, et al. Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma. Front Oncol. 2018;8:462.PubMedPubMedCentral
4.
5.
6.
Hamilton JG, Genoff Garzon M, Westerman JS, Shuk E, Hay JL, Walters C, et al. “A Tool, Not a Crutch”: patient perspectives about IBM Watson for Oncology trained by Memorial Sloan Kettering. JOP. 2019;15:e277–88.PubMed
7.
Choi YI, Chung J, Kim KO, Kwon KA, Kim YJ, Park DK, et al. Concordance rate between clinicians and Watson for oncology among patients with advanced gastric cancer: early, real-world experience in Korea. Can J Gastroenterol Hepatol. 2019;2019:8072928.PubMedPubMedCentral
8.
9.
Shahid N, Rappon T, Berta W. Applications of artificial neural networks in health care organizational decision-making: a scoping review. PLoS ONE. 2019;14:e0212356.PubMedPubMedCentral
10.
Choy G, Khalilzadeh O, Michalski M, Do S, Samir AE, Pianykh OS, et al. Current applications and future impact of machine learning in radiology. Radiology. 2018;288:318–28.PubMedPubMedCentral
11.
Yamashita R, Nishio M, Do RKG, Togashi K. Convolutional neural networks: an overview and application in radiology. Insights Imaging. 2018;9:611–29.PubMedPubMedCentral
12.
13.
14.
Sikchi SS, Sikchi S, Ali MS. Artificial intelligence in medical diagnosis. Int J Appl Eng Res. 2012;7:1539–43.
15.
Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol Sci. 2019;40:577–91.PubMed
16.
17.
Wirtz BW, Weyerer JC. Artificial intelligence in the public sector. In: Farazmand A, editor. Global encyclopedia of public administration, public policy, and governance [Internet]. Cham: Springer International Publishing; 2019 [cited 2020 Nov 14]. p. 1–7. Available from: https://​doi.​org/​10.​1007/​978-3-319-31816-5_​3701-1.
18.
Kersting K. Machine learning and artificial intelligence: two fellow travelers on the quest for intelligent behavior in machines. Front Big Data. 2018;1:6.PubMedPubMedCentral
19.
20.
McBee MP, Awan OA, Colucci AT, Ghobadi CW, Kadom N, Kansagra AP, et al. Deep learning in radiology. Acad Radiol. 2018;25:1472–80.PubMed
21.
22.
23.
24.
25.
Lee E-J, Kim Y-H, Kim N, Kang D-W. Deep into the brain: artificial intelligence in stroke imaging. J Stroke. 2017;19:277–85.PubMedPubMedCentral
26.
Ghorbanzadeh O, Blaschke T, Gholamnia K, Meena SR, Tiede D, Aryal J. Evaluation of different machine learning methods and deep-learning convolutional neural networks for landslide detection. Remote Sens. 2019;11:196.
27.
Fakoor R, Ladhak F, Nazi A, Huber M. Using deep learning to enhance cancer diagnosis and classification. In: Proceedings of the ICML Workshop on the Role of Machine Learning in Transforming Healthcare. 2013.
28.
Azer SA. Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: a systematic review. World J Gastrointest Oncol. 2019;11:1218–30.PubMedPubMedCentral
29.
30.
31.
32.
33.
Davenport TH, Glaser J. Just-in-time delivery comes to knowledge management. Harv Bus Rev. 2002;80(107–11):126.
34.
Zanagnolo V, Garbi A, Achilarre MT, Minig L. Robot-assisted surgery in gynecologic cancers. J Minim Invasive Gynecol. 2017;24:379–96.PubMed
35.
Kalantari F, Rajaeih S, Daneshvar A, Karbasi Z, Mahdi Salem M. Robotic surgery of head and neck cancers, a narrative review. Eur J Transl Myol. 2020;30:8727.PubMedPubMedCentral
36.
Zorn KC, Gofrit ON, Steinberg GD, Shalhav AL. Evolution of robotic surgery in the treatment of localized prostate cancer. Curr Treat Options Oncol. 2007;8:197–210.PubMed
37.
Obuchowski NA, Bullen JA. Statistical considerations for testing an AI algorithm used for prescreening lung CT images. Contemp Clin Trials Commun. 2019;16:100434.PubMedPubMedCentral
38.
Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4:627–35.PubMedPubMedCentral
39.
Wang Z, Wang E, Zhu Y. Image segmentation evaluation: a survey of methods. Artif Intell Rev. 2020;53:5637–74.
40.
41.
Zhou N, Zhang C, Lv H, Hao C, Li T, Zhu J, et al. Concordance study between IBM Watson for oncology and clinical practice for patients with cancer in China. Oncologist. 2019;24:812–9.PubMed
42.
43.
Rysavy M. Evidence-based medicine: a science of uncertainty and an art of probability. AMA J Ethics. 2013;15:4–8.
44.
45.
46.
Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108:479–85.PubMedPubMedCentral
47.
48.
Rudie JD, Rauschecker AM, Bryan RN, Davatzikos C, Mohan S. Emerging applications of artificial intelligence in neuro-oncology. Radiology. 2019;290:607–18.PubMedPubMedCentral
49.
Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol. 2003;30:4–9.PubMed
50.
Alieva M, van Rheenen J, Broekman MLD. Potential impact of invasive surgical procedures on primary tumor growth and metastasis. Clin Exp Metastasis. 2018;35:319–31.PubMedPubMedCentral
51.
Kong K, Rowlands CJ, Varma S, Perkins W, Leach IH, Koloydenko AA, et al. Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy. Proc Natl Acad Sci USA. 2013;110:15189–94.PubMed
52.
53.
54.
Wu C-C, Guo W-Y, Chen M-H, Ho DMT, Hung ASC, Chung H-W. Direct measurement of the signal intensity of diffusion-weighted magnetic resonance imaging for preoperative grading and treatment guidance for brain gliomas. J Chin Med Assoc. 2012;75:581–8.PubMed
55.
Li-Chun Hsieh K, Chen C-Y, Lo C-M. Quantitative glioma grading using transformed gray-scale invariant textures of MRI. Comput Biol Med. 2017;83:9283480.
56.
Wen PY, Huse JT. 2016 World Health Organization classification of central nervous system tumors. CONTINUUM. 2017;23:1531.PubMed
57.
Tian Q, Yan L-F, Zhang X, Zhang X, Hu Y-C, Han Y, et al. Radiomics strategy for glioma grading using texture features from multiparametric MRI. J Magn Reson Imaging. 2018;48:1518–28.PubMed
58.
Mao Y, Liao W, Cao D, Zhao L, Wu X, Kong L, et al. An artificial neural network model for glioma grading using image information. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:1315–22.PubMed
59.
Ranjith G, Parvathy R, Vikas V, Chandrasekharan K, Nair S. Machine learning methods for the classification of gliomas: initial results using features extracted from MR spectroscopy. Neuroradiol J. 2015;28:106–11.PubMedPubMedCentral
60.
Zhang X, Yan L-F, Hu Y-C, Li G, Yang Y, Han Y, et al. Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features. Oncotarget. 2017;8:47816–30.PubMedPubMedCentral
61.
Brat D, Prayson R, Ryken T, Olson J. Diagnosis of malignant glioma: role of neuropathology. J Neurooncol. 2008;89:287–311.PubMed
62.
Sonoda Y, Shibahara I, Kawaguchi T, Saito R, Kanamori M, Watanabe M, et al. Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol. 2015;32:99–104.PubMed
63.
Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol. 2019;30:1265–78.PubMedPubMedCentral
64.
Modrek AS, Golub D, Khan T, Bready D, Prado J, Bowman C, et al. Low-grade astrocytoma mutations in IDH1, P53 and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Rep. 2017;21:1267–80.PubMedPubMedCentral
65.
Wu S, Meng J, Yu Q, Li P, Fu S. Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas. J Cancer Res Clin Oncol. 2019;145:543–50.PubMedPubMedCentral
66.
Zhang B, Chang K, Ramkissoon S, Tanguturi S, Bi WL, Reardon DA, et al. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro Oncol. 2017;19:109–17.PubMed
67.
Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ. Residual deep convolutional neural network predicts MGMT methylation status. J Digit Imaging. 2017;30:622–8.PubMedPubMedCentral
68.
Han L, Kamdar MR. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks. Pac Symp Biocompt. 2018; 23: 331–42. Available from: https://​www.​worldscientific.​com/​doi/​abs/​https://​doi.​org/​10.​1142/​9789813235533_​0031.
69.
Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom KW, et al. Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol. 2018;39:208–16.PubMed
70.
Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, et al. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Am J Surg Pathol. 2006;30:828–37.PubMed
71.
Parsons DW, Jones S, Zhang X, Lin JC–H, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807–12.PubMedPubMedCentral
72.
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765–73.PubMedPubMedCentral
73.
Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, et al. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F] FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol. 2012;14:1473–80.PubMedPubMedCentral
74.
Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol. 2010;120:707–18.PubMed
75.
Fellah S, Caudal D, Paula AMD, Dory-Lautrec P, Figarella-Branger D, Chinot O, et al. Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis? Am J Neuroradiol. 2013;34:1326–33.PubMed
76.
Bourdillon P, Hlaihel C, Guyotat J, Guillotton L, Honnorat J, Ducray F, et al. Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status. J Neurooncol. 2015;122:529–37.PubMed
77.
Iwadate Y, Shinozaki N, Matsutani T, Uchino Y, Saeki N. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. J Neurol Neurosurg Psychiatry. 2016;87:1016–21.PubMedPubMedCentral
78.
Hu N, Richards R, Jensen R. Role of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas: a systematic review and meta-analysis. Interdiscip Neurosurg. 2016;5:58–63.
79.
Akkus Z, Ali I, Sedlář J, Agrawal JP, Parney IF, Giannini C, et al. Predicting deletion of chromosomal arms 1p/19q in low-grade gliomas from MR images using machine intelligence. J Digit Imaging. 2017;30:469–76.PubMedPubMedCentral
80.
Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. Am J Neuroradiol. 2018;39:1201–7.PubMed
81.
Liu J, Chen F, Pan C, Zhu M, Zhang X, Zhang L, et al. A cascaded deep convolutional neural network for joint segmentation and genotype prediction of brainstem gliomas. IEEE Trans Biomed Eng. 2018;65:1943–52.PubMed
82.
Bilgin C, Demir C, Nagi C, Yener B. Cell-graph mining for breast tissue modeling and classification. In: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2007. p. 5311–4.
83.
Sertel O, Kong J, Catalyurek UV, Lozanski G, Saltz JH, Gurcan MN. Histopathological image analysis using model-based intermediate representations and color texture: follicular lymphoma grading. J Sign Process Syst Sign Image Video Technol. 2008;55:169.
84.
Gurcan MN, Boucheron LE, Can A, Madabhushi A, Rajpoot NM, Yener B. Histopathological image analysis: a review. IEEE Rev Biomed Eng. 2009;2:147–71.PubMedPubMedCentral
85.
Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol. 2004;35:1179–88.PubMed
86.
Rodenacker K, Bengtsson E. A feature set for cytometry on digitized microscopic images. Anal Cell Pathol. 2003;25:1–36.PubMedPubMedCentral
87.
Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology. Nat Rev Clin Oncol. 2019;16:703–15.PubMedPubMedCentral
88.
89.
Fukuma K, Prasath VBS, Kawanaka H, Aronow BJ, Takase H. A study on nuclei segmentation, feature extraction and disease stage classification for human brain histopathological images. Proc Comput Sci. 2016;96:1202–10.
90.
Wang X, Wang D, Yao Z, Xin B, Wang B, Lan C, et al. Machine learning models for multiparametric glioma grading with quantitative result interpretations. Front Neurosci. 2019;11:1046.
91.
Yonekura A, Kawanaka H, Prasath VBS, Aronow BJ, Takase H. Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network. Biomed Eng Lett. 2018;8:321–7.PubMedPubMedCentral
92.
Ker J, Bai Y, Lee HY, Rao J, Wang L. Automated brain histology classification using machine learning. J Clin Neurosci. 2019;66:239–45.PubMed
93.
Gordillo N, Montseny E, Sobrevilla P. State of the art survey on MRI brain tumor segmentation. Magn Reson Imaging. 2013;31:1426–38.PubMed
94.
LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44.
95.
Litjens G, Kooi T, Bejnordi BE, Setio AAA, Ciompi F, Ghafoorian M, et al. A survey on deep learning in medical image analysis. Med Image Anal. 2017;42:60–88.PubMed
96.
Lotan E, Jain R, Razavian N, Fatterpekar GM, Lui YW. State of the art: machine learning applications in glioma imaging. Am J Roentgenol. 2018;212:26–37.
97.
Tustison NJ, Shrinidhi KL, Wintermark M, Durst CR, Kandel BM, Gee JC, et al. Optimal symmetric multimodal templates and concatenated random forests for supervised brain tumor segmentation (simplified) with ANTsR. Neuroinformatics. 2015;13:209–25.PubMed
98.
Pereira S, Pinto A, Alves V, Silva CA. Brain tumor segmentation using convolutional neural networks in MRI images. IEEE Trans Med Imaging. 2016;35:1240–51.PubMed
99.
Havaei M, Davy A, Warde-Farley D, Biard A, Courville A, Bengio Y, et al. Brain tumor segmentation with deep neural networks. Med Image Anal. 2017;35:18–31.PubMed
100.
Kamnitsas K, Ledig C, Newcombe VFJ, Simpson JP, Kane AD, Menon DK, et al. Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal. 2017;36:61–78.PubMed
101.
Cui S, Mao L, Jiang J, Liu C, Xiong S. Automatic semantic segmentation of brain gliomas from MRI images using a deep cascaded neural network. J Healthc Eng. 2018;2018:4940593.PubMedPubMedCentral
102.
Blanc-Durand P, Gucht AVD, Schaefer N, Itti E, Prior JO. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: a full 3D U-Net convolutional neural network study. PLoS ONE. 2018;13:e0195798.PubMedPubMedCentral
103.
Li Z, Wang Y, Yu J, Shi Z, Guo Y, Chen L, et al. Low-grade glioma segmentation based on CNN with fully connected CRF. J Healthc Eng. 2017;2017:9283480.PubMedPubMedCentral
104.
105.
Sengupta A, Agarwal S, Gupta PK, Ahlawat S, Patir R, Gupta RK, et al. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images. Eur J Radiol. 2018;106:199–208.PubMed
106.
Bonte S, Goethals I, Van Holen R. Machine learning based brain tumour segmentation on limited data using local texture and abnormality. Comput Biol Med. 2018;98:39–47.PubMed
107.
Garzon-Muvdi T, Kut C, Li X, Chaichana KL. Intraoperative imaging techniques for glioma surgery. Future Oncol. 2017;13:1731–45.PubMedPubMedCentral
108.
Fabelo H, Halicek M, Ortega S, Shahedi M, Szolna A, Piñeiro JF, et al. Deep learning-based framework for in vivo identification of glioblastoma tumor using hyperspectral images of human brain. Sensors. 2019;19:920.
109.
Zhang H, Wang R, Yu Y, Liu J, Luo T, Fan F. Glioblastoma treatment modalities besides surgery. J Cancer. 2019;10:4793–806.PubMedPubMedCentral
110.
Daisne J-F, Blumhofer A. Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation. Radiat Oncol. 2013;8:154.PubMedPubMedCentral
111.
Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI. Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging. 2018;2018:6828396.PubMedPubMedCentral
112.
Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging. 2018;9:1057–75.PubMedPubMedCentral
113.
Hu X, Wong KK, Young GS, Guo L, Wong ST. Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging. 2011;33:296–305.PubMedPubMedCentral
114.
Jang B-S, Jeon SH, Kim IH, Kim IA. Prediction of pseudoprogression versus progression using machine learning algorithm in glioblastoma. Sci Rep. 2018;8:12516.PubMedPubMedCentral
115.
Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2014;13:8–17.PubMedPubMedCentral
116.
Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, et al. A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep. 2017;7:10353.PubMedPubMedCentral
117.
Nie D, Lu J, Zhang H, Adeli E, Wang J, Yu Z, et al. Multi-channel 3D deep feature learning for survival time prediction of brain tumor patients using multi-modal neuroimages. Sci Rep. 2019;9:1103.PubMedPubMedCentral
118.
Sarkiss CA, Germano IM. Machine learning in neuro-oncology: can data analysis from 5346 patients change decision-making paradigms? World Neurosurg. 2019;124:287–94.
119.
Calabrese E, Villanueva-Meyer JE, Cha S. A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas. Sci Rep. 2020;10:11852.PubMedPubMedCentral
120.
Veronese E, Castellani U, Peruzzo D, Bellani M, Brambilla P. Machine learning approaches: from theory to application in schizophrenia. Comput Math Methods Med. 2013;2013:867924.PubMedPubMedCentral
121.
Mehdy MM, Ng PY, Shair EF, Saleh NIM, Gomes C. Artificial neural networks in image processing for early detection of breast cancer. Comput Math Methods Med. 2017;2017:2610628.PubMedPubMedCentral
122.
Metadata
Title
Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?
Authors
Precilla S Daisy
T. S. Anitha
Publication date
01-05-2021
Publisher
Springer US
Published in
Medical Oncology / Issue 5/2021
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-021-01500-2

Other articles of this Issue 5/2021

Medical Oncology 5/2021 Go to the issue

Review Article

The role of interleukins and the widely studied TNF-α in non-Hodgkin’s lymphoma

Review Article

Immunotherapy and predictive immunologic profile: the tip of the iceberg

Review Article

Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

Review Article

The role of various interleukins in acute myeloid leukemia

Original Paper

SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer

Original Paper

OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits